Cargando…

Defining aggressive prostate cancer: a geospatial perspective

BACKGROUND: Spatial analysis can identify communities where men are at risk for aggressive prostate cancer (PCan) and need intervention. However, there are several definitions for aggressive PCan. In this study, we evaluate geospatial patterns of 3 different aggressive PCan definitions in relation t...

Descripción completa

Detalles Bibliográficos
Autores principales: Wiese, Daniel, DuBois, Tesla D., Sorice, Kristen A., Fang, Carolyn Y., Ragin, Camille, Daly, Mary B., Reese, Adam C., Henry, Kevin A., Lynch, Shannon M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10424402/
https://www.ncbi.nlm.nih.gov/pubmed/37580675
http://dx.doi.org/10.1186/s12885-023-11281-8
_version_ 1785089668703846400
author Wiese, Daniel
DuBois, Tesla D.
Sorice, Kristen A.
Fang, Carolyn Y.
Ragin, Camille
Daly, Mary B.
Reese, Adam C.
Henry, Kevin A.
Lynch, Shannon M.
author_facet Wiese, Daniel
DuBois, Tesla D.
Sorice, Kristen A.
Fang, Carolyn Y.
Ragin, Camille
Daly, Mary B.
Reese, Adam C.
Henry, Kevin A.
Lynch, Shannon M.
author_sort Wiese, Daniel
collection PubMed
description BACKGROUND: Spatial analysis can identify communities where men are at risk for aggressive prostate cancer (PCan) and need intervention. However, there are several definitions for aggressive PCan. In this study, we evaluate geospatial patterns of 3 different aggressive PCan definitions in relation to PCan-specific mortality and provide methodologic and practical insights into how each definition may affect intervention targets. METHODS: Using the Pennsylvania State Cancer Registry data (2005–2015), we used 3 definitions to assign “aggressive” status to patients diagnosed with PCan. Definition one (D1, recently recommended as the primary definition, given high correlation with PCan death) was based on staging criteria T4/N1/M1 or Gleason score ≥ 8. Definition two (D2, most frequently-used definition in geospatial studies) included distant SEER summary stage. Definition three (D3) included Gleason score ≥ 7 only. Using Bayesian spatial models, we identified geographic clusters of elevated odds ratios for aggressive PCan (binomial model) for each definition and compared overlap between those clusters to clusters of elevated hazard ratios for PCan-specific mortality (Cox regression). RESULTS: The number of “aggressive” PCan cases varied by definition, and influenced quantity, location, and extent/size of geographic clusters in binomial models. While spatial patterns overlapped across all three definitions, using D2 in binomial models provided results most akin to PCan-specific mortality clusters as identified through Cox regression. This approach resulted in fewer clusters for targeted intervention and less sensitive to missing data compared to definitions that rely on clinical TNM staging. CONCLUSIONS: Using D2, based on distant SEER summary stage, in future research may facilitate consistency and allow for standardized comparison across geospatial studies. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12885-023-11281-8.
format Online
Article
Text
id pubmed-10424402
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-104244022023-08-15 Defining aggressive prostate cancer: a geospatial perspective Wiese, Daniel DuBois, Tesla D. Sorice, Kristen A. Fang, Carolyn Y. Ragin, Camille Daly, Mary B. Reese, Adam C. Henry, Kevin A. Lynch, Shannon M. BMC Cancer Research BACKGROUND: Spatial analysis can identify communities where men are at risk for aggressive prostate cancer (PCan) and need intervention. However, there are several definitions for aggressive PCan. In this study, we evaluate geospatial patterns of 3 different aggressive PCan definitions in relation to PCan-specific mortality and provide methodologic and practical insights into how each definition may affect intervention targets. METHODS: Using the Pennsylvania State Cancer Registry data (2005–2015), we used 3 definitions to assign “aggressive” status to patients diagnosed with PCan. Definition one (D1, recently recommended as the primary definition, given high correlation with PCan death) was based on staging criteria T4/N1/M1 or Gleason score ≥ 8. Definition two (D2, most frequently-used definition in geospatial studies) included distant SEER summary stage. Definition three (D3) included Gleason score ≥ 7 only. Using Bayesian spatial models, we identified geographic clusters of elevated odds ratios for aggressive PCan (binomial model) for each definition and compared overlap between those clusters to clusters of elevated hazard ratios for PCan-specific mortality (Cox regression). RESULTS: The number of “aggressive” PCan cases varied by definition, and influenced quantity, location, and extent/size of geographic clusters in binomial models. While spatial patterns overlapped across all three definitions, using D2 in binomial models provided results most akin to PCan-specific mortality clusters as identified through Cox regression. This approach resulted in fewer clusters for targeted intervention and less sensitive to missing data compared to definitions that rely on clinical TNM staging. CONCLUSIONS: Using D2, based on distant SEER summary stage, in future research may facilitate consistency and allow for standardized comparison across geospatial studies. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12885-023-11281-8. BioMed Central 2023-08-14 /pmc/articles/PMC10424402/ /pubmed/37580675 http://dx.doi.org/10.1186/s12885-023-11281-8 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Wiese, Daniel
DuBois, Tesla D.
Sorice, Kristen A.
Fang, Carolyn Y.
Ragin, Camille
Daly, Mary B.
Reese, Adam C.
Henry, Kevin A.
Lynch, Shannon M.
Defining aggressive prostate cancer: a geospatial perspective
title Defining aggressive prostate cancer: a geospatial perspective
title_full Defining aggressive prostate cancer: a geospatial perspective
title_fullStr Defining aggressive prostate cancer: a geospatial perspective
title_full_unstemmed Defining aggressive prostate cancer: a geospatial perspective
title_short Defining aggressive prostate cancer: a geospatial perspective
title_sort defining aggressive prostate cancer: a geospatial perspective
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10424402/
https://www.ncbi.nlm.nih.gov/pubmed/37580675
http://dx.doi.org/10.1186/s12885-023-11281-8
work_keys_str_mv AT wiesedaniel definingaggressiveprostatecancerageospatialperspective
AT duboisteslad definingaggressiveprostatecancerageospatialperspective
AT soricekristena definingaggressiveprostatecancerageospatialperspective
AT fangcarolyny definingaggressiveprostatecancerageospatialperspective
AT ragincamille definingaggressiveprostatecancerageospatialperspective
AT dalymaryb definingaggressiveprostatecancerageospatialperspective
AT reeseadamc definingaggressiveprostatecancerageospatialperspective
AT henrykevina definingaggressiveprostatecancerageospatialperspective
AT lynchshannonm definingaggressiveprostatecancerageospatialperspective